From microarray to bedside: targeting NF-kappaB for therapy of lymphomas.
Rabson
Arnold B
AB
Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey, New Brunswick, NJ, USA. rabson@cabm.rutgers.edu
Weissmann
David
D
D000818:Animals; D017209:Apoptosis; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D016393:Lymphoma, B-Cell / Q000378:metabolism / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000378:metabolism / Q000628:therapy*; D008954:Models, Biological; D016328:NF-kappa B / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods*; D011379:Prognosis; D015398:Signal Transduction
D016328:NF-kappa B